Skip to main content

Phantom Limb Pain

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Mirror TherapyPhase 11 trial
Active Trials
NCT00827294Completed40Est. Nov 2010
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Experimental Electrical Stimulation RegimenN/A1 trial
Active Trials
NCT03030079Completed10Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsMirror Therapy
Colorado TherapeuticsExperimental Electrical Stimulation Regimen

Clinical Trials (2)

Total enrollment: 50 patients across 2 trials

Home-based Self-delivered Mirror Therapy for Phantom Limb Pain

Start: Jan 2009Est. completion: Nov 201040 patients
Phase 1Completed
NCT03030079Colorado TherapeuticsExperimental Electrical Stimulation Regimen

Electrical Stimulus Therapy for Chronic Phantom Limb Pain

Start: Jan 2017Est. completion: Jun 202310 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.